Related Experiment Video
Updated: May 10, 2026
06:09
An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
Phyto diab care: Phytoremedial database for antidiabetics
Shruti Luhach1, Anshita Goel, Gohar Taj
1Department of Molecular Biology & Genetic Engineering College of Basic Sciences & Humanities G.B. Pant University of Agriculture & Technology, Pantnagar-263 145 India.
Bioinformation
|June 11, 2013
Summary
Phyto Diab Care is a new database that uses traditional knowledge of medicinal plants to find natural treatments for diabetes. It helps researchers identify safe and effective plant-based compounds to manage blood sugar levels.
Area of Science:
- Phytochemistry
- Bioinformatics
- Pharmacology
Background:
- Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia.
- Current pharmaceutical treatments for diabetes can cause adverse effects.
- Traditional medicine offers a potential source for novel antidiabetic compounds.
Purpose of the Study:
- To develop a comprehensive phytoremedial database for antidiabetic medicinal plants and phytochemicals.
- To leverage traditional knowledge for discovering safe and effective diabetes treatments.
- To provide a searchable resource for researchers in phytomedicine.
Main Methods:
- Data compilation from peer-reviewed literature.
- Development of a customizable relational database (Phyto Diab Care).
- Integration of phytochemical data, 2D/3D structures, and molecular docking information.
Main Results:
- The Phyto Diab Care database offers rapid and accurate data retrieval.
- An enhanced web interface enables multi-criteria filtering of information.
- The resource includes molecular docking data for efficacy assessment on insulin pathways.
Conclusions:
- Phyto Diab Care is a valuable, publicly accessible resource for exploring plant-based diabetes treatments.
- The database facilitates the identification of novel antidiabetic phytochemicals with reduced side effects.
- It supports research into traditional medicine for managing diabetes effectively.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:16Antihypertensive Drugs: Action of Diuretics
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...